Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Get the latest updates from Investor Update directly as they happen.
Follow now 341 followers
Last updated 1 day ago
1 day ago
We are pleased to invite investors and analysts to participate in our...
4 days ago
Shareholders approved all proposals of the Board of Directors Severin Schwan was...
5 days ago
Roche will publish its Sales Results for the 1st Quarter 2025 prior...
12 days ago
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of...
17 days ago
Agreement allows for a range of potentially best-in-class therapy options as monotherapy...
24 days ago
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III...
25 days ago
We are pleased to invite investors and analysts to participate in our...
27 days ago
First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) Results were featured...
29 days ago
Columvi plus chemotherapy showed a 41% reduction in the risk of death...
about 1 month ago
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in...
about 1 month ago
We are pleased to invite investors and analysts to participate in our...
about 2 months ago
We are pleased to invite investors and analysts to participate in our...